Health Care
Blog
Getting the Drug Spending Facts Right
In a typical rant, Senator Sanders claimed in a September 15th press release that “at a time when the drug companies are charging us by far the highest prices in the world, Congress must demand that Medicare negotiate prices with this extremely greedy and powerful industry.” The Senator clearly misunderstands ...
Business & Economics
Jon Miltimore – The Push for Socialism and Economic Restrictions in the Name of the Pandemic
Enjoy this recent conversation between Jon Miltimore of the Foundation for Economic Education and PRI’s Evan Harris for our Young Leaders Circle Speaker Series. They discuss socialism, progressive politics, economic news, and the latest pandemic restrictions.
Commentary
Single-Payer Will Worsen Healthcare Workers’ Plight
Healthcare workers are exchanging scrubs and gloves for signs and megaphones. In what’s been called “Striketober,” frontline staff are walking out of hospitals, emergency rooms, and doctor’s offices to insist on better pay, benefits, and hours. Earlier this month, Kaiser Permanente workers in California voted to authorize a strike over ...
Coronavirus
Dr. Henry Miller Explains COVID Rapid Tests with Lars Larson
Dr. Henry Miller, M.S., M.D., joins the nationally-syndicated Lars Larson Show to talk about how the U.S. Food and Drug Administration, FDA, blocked a crucial test, the rapid response antigen test, to help with COVID-19 testing. The test is an at-home test that takes roughly 20 minutes. Dr. Miller explains ...
Blog
Local Government COVID-19 Relief Funds Bonuses for Government Workers
Earlier this year, Congress enacted $350 billion in “state and local government aid” as part of the so-called American Rescue Plan. This is in addition to receiving $150 billion in relief in the first federal Coronavirus Relief Fund enacted in March 2020, and which according to a recent estimate, state ...
Featured
New PRI Series to Show How Flawed U.S. Health Insurance System Inflates Costs, Decreases Quality and Reduces Health Outcomes
Addressing the ongoing problems with the U.S. health insurance system, the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute today announced the release of the first paper in the Coverage Denied series, which will analyze and propose reforms to fix the problems in the current system ...
Commentary
Sally Pipes: Democrats’ Drug Pricing Reforms Aren’t What They Seem
As part of their spending bill, Congressional Democrats are advancing legislation that’ll empower Medicare to “negotiate” drug prices in the program’s Part B and Part D benefits. They insist this policy enjoys broad support among voters. But they’re misleading the public. What Democrats are proposing is in fact a sweeping ...
Blog
Gallup Survey: Americans Push Back on Government Activism
It was 35 years ago when Ronald Reagan said at a press conference, “The most terrifying words in the English language are: I’m from the government and I’m here to help.” And for most of the last three decades, a majority of Americans agreed with the Gipper. Last year marked only ...
Drug Pricing
NEW BRIEF: Focus Groups Overwhelmingly Disapprove of Government “Negotiated” Drug Pricing
Today, the Pacific Research Institute published an issue brief revealing overwhelming public disapproval for Medicare reforms that Congress is considering as part of its $3.5 trillion spending bill. Click here to read the full issue brief, “Drug Pricing Proposals Threaten America’s Most Vulnerable Patients.” “It’s a relief that Americans oppose ...
Commentary
Democrats Have Built a Healthcare Agenda Around an Imaginary Crisis
Is America in the midst of a health insurance crisis? That’s the picture Democrats in Washington are painting. According to their narrative, health coverage is out of reach for a number of Americans. Only an aggressive — and exorbitantly expensive — effort to expand the number of people covered by taxpayer-funded insurance ...
Getting the Drug Spending Facts Right
In a typical rant, Senator Sanders claimed in a September 15th press release that “at a time when the drug companies are charging us by far the highest prices in the world, Congress must demand that Medicare negotiate prices with this extremely greedy and powerful industry.” The Senator clearly misunderstands ...
Jon Miltimore – The Push for Socialism and Economic Restrictions in the Name of the Pandemic
Enjoy this recent conversation between Jon Miltimore of the Foundation for Economic Education and PRI’s Evan Harris for our Young Leaders Circle Speaker Series. They discuss socialism, progressive politics, economic news, and the latest pandemic restrictions.
Single-Payer Will Worsen Healthcare Workers’ Plight
Healthcare workers are exchanging scrubs and gloves for signs and megaphones. In what’s been called “Striketober,” frontline staff are walking out of hospitals, emergency rooms, and doctor’s offices to insist on better pay, benefits, and hours. Earlier this month, Kaiser Permanente workers in California voted to authorize a strike over ...
Dr. Henry Miller Explains COVID Rapid Tests with Lars Larson
Dr. Henry Miller, M.S., M.D., joins the nationally-syndicated Lars Larson Show to talk about how the U.S. Food and Drug Administration, FDA, blocked a crucial test, the rapid response antigen test, to help with COVID-19 testing. The test is an at-home test that takes roughly 20 minutes. Dr. Miller explains ...
Local Government COVID-19 Relief Funds Bonuses for Government Workers
Earlier this year, Congress enacted $350 billion in “state and local government aid” as part of the so-called American Rescue Plan. This is in addition to receiving $150 billion in relief in the first federal Coronavirus Relief Fund enacted in March 2020, and which according to a recent estimate, state ...
New PRI Series to Show How Flawed U.S. Health Insurance System Inflates Costs, Decreases Quality and Reduces Health Outcomes
Addressing the ongoing problems with the U.S. health insurance system, the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute today announced the release of the first paper in the Coverage Denied series, which will analyze and propose reforms to fix the problems in the current system ...
Sally Pipes: Democrats’ Drug Pricing Reforms Aren’t What They Seem
As part of their spending bill, Congressional Democrats are advancing legislation that’ll empower Medicare to “negotiate” drug prices in the program’s Part B and Part D benefits. They insist this policy enjoys broad support among voters. But they’re misleading the public. What Democrats are proposing is in fact a sweeping ...
Gallup Survey: Americans Push Back on Government Activism
It was 35 years ago when Ronald Reagan said at a press conference, “The most terrifying words in the English language are: I’m from the government and I’m here to help.” And for most of the last three decades, a majority of Americans agreed with the Gipper. Last year marked only ...
NEW BRIEF: Focus Groups Overwhelmingly Disapprove of Government “Negotiated” Drug Pricing
Today, the Pacific Research Institute published an issue brief revealing overwhelming public disapproval for Medicare reforms that Congress is considering as part of its $3.5 trillion spending bill. Click here to read the full issue brief, “Drug Pricing Proposals Threaten America’s Most Vulnerable Patients.” “It’s a relief that Americans oppose ...
Democrats Have Built a Healthcare Agenda Around an Imaginary Crisis
Is America in the midst of a health insurance crisis? That’s the picture Democrats in Washington are painting. According to their narrative, health coverage is out of reach for a number of Americans. Only an aggressive — and exorbitantly expensive — effort to expand the number of people covered by taxpayer-funded insurance ...
